Discovery of new antimalarials from commercial drugs by in silico and in vitro screening

被引：0

作者：

Machado Tugores, Yanetsy ^{[1
]}

Meneses Marcel, Alfredo ^{[1
]}

Marrero Ponce, Yovani ^{[2
,3
]}

Aran, Vicente J. ^{[4
]}

Escario Garcia-Trevijano, Jose Antonio ^{[5
]}

Huong Le Thi Thu ^{[2
]}

Garcia Sanchez, Rory N.

Gomez Barrio, Alicia ^{[5
]}

机构：

[1] Univ Cent Martha Abreu Las Villas UCLV, Ctr Bioact Quim, Dept Parasitol, Santa Clara 54830, Villa Clara, Cuba

[2] UCLV, Fac Quim Farm, Unit Computer Aided Mol Biosil Discovery & Bioinf, Santa Clara 54830, Villa Clara, Cuba

[3] Univ Valencia, Inst Univ Ciencia Mol, E-46071 Valencia, Spain

[4] CSIC, Inst Quim Med, E-28006 Madrid, Spain

[5] Univ Complutense Madrid, Fac Farm, Dept Parasitol, E-28040 Madrid, Spain

来源：

ANALES DE LA REAL ACADEMIA NACIONAL DE FARMACIA | 2012年 / 78卷 / 04期

关键词：

Antimalarial drug; Virtual screening; Plasmdium falciparum;

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Increased efforts in antimalarial drug discovery are urgently needed. This paper applies a virtual screening protocol consisting of different computational filters in order to identify new antimalarial scaffolds from a structurally diverse library. This procedure has retained 38 new virtual hit which 12 were selected for experimental evaluation against Plasmodium falciparum, 3 of them showed significant antimalarial activity. These compounds have diverse chemical structures unrelated to existing antimalarial drugs can therefore be considered as new lead compounds, which leave an open door to the development of new antimalarials.

引用

页码：461 / 498

页数：34

共 50 条

[1] SCREENING DRUGS FOR ANTIMALARIALS
不详
CHEMICAL & ENGINEERING NEWS, 2011, 89 (32) : 39 - 39
[2] In Silico and In Vitro: Identifying New Drugs
Pauli, Ivani
Saraiva Macedo Timmers, Luis Fernando
Caceres, Rafael Andrade
Pereira Soares, Milena Botelho
de Azevedo, Walter Filgueira, Jr.
CURRENT DRUG TARGETS, 2008, 9 (12) : 1054 - 1061
[3] In vitro and in silico screening of novel typhoid drugs from endangered herb (Enicostema axillare)
Perumal, Sasidharan
Samy, MadhanaVigneshwari Gopal
Subramanian, Dharaneedharan
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (07): : 2926 - 2936
[4] Integrated In Vitro-In Silico Screening Strategy for the Discovery of Antibacterial Compounds
Nybond, Susanna
Ghemtio, Leo
Nawrot, Dorota A.
Karp, Matti
Xhaard, Henri
Tammela, Paivi
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2015, 13 (01) : 25 - 33
[5] Drugs Polypharmacology by In Silico Methods: New Opportunities in Drug Discovery
Lauria, Antonino
Bonsignore, Riccardo
Bartolotta, Roberta
Perricone, Ugo
Martorana, Annamaria
Gentile, Carla
CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (21) : 3073 - 3081
[6] A bioinorganic approach to the discovery of new antimalarials
Egan, TJ
Hunter, R
Kaschula, CH
Ncokazi, KK
JOURNAL OF INORGANIC BIOCHEMISTRY, 2001, 86 (01) : 43 - 43
[7] Discovery of New Inhibitors of eEF2K from Traditional Chinese Medicine Based on In Silico Screening and In Vitro Experimental Validation
Fu, Qinghua
Liu, Xiaomei
Li, Yan
Wang, Peng
Wu, Tian
Xiao, Haihan
Zhao, Yameng
Liao, Qichao
Song, Ziyi
MOLECULES, 2022, 27 (15):
[8] In vitro, in silico and in vivo screening of non-oncology drugs for repurposing in osteosarcoma
Desai, Sujit
Manjappa, Arehalli
Khulbe, Preeti
Choudhar, Prafulla
Kumbhar, Popat
JOURNAL OF RESEARCH IN PHARMACY, 2023, 27 (02): : 712 - 721
[9] In silico screening needed for drug discovery
Studt, T
R&D MAGAZINE, 2002, 44 (08): : 31 - 33
[10] Discovery of Dual ETA/ETB Receptor Antagonists from Traditional Chinese Herbs through in Silico and in Vitro Screening
Wang, Xing
Zhang, Yuxin
Liu, Qing
Ai, Zhixin
Zhang, Yanling
Xiang, Yuhong
Qiao, Yanjiang
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (03):

← 1 2 3 4 5 →